Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/192183
Full metadata record
DC FieldValueLanguage
dc.contributor.authorFerreiro Iglesias, Rocío-
dc.contributor.authorPiqueras, Marta-
dc.contributor.authorRicart, Elena-
dc.contributor.authorSempere, Laura-
dc.contributor.authorRoca, Mariona-
dc.contributor.authorMartín de Carpi, Javier-
dc.contributor.authorBenítez, Olga-
dc.contributor.authorZabana, Yamile-
dc.contributor.authorMañosa, Míriam-
dc.contributor.authorRodríguez Moranta, Francisco-
dc.contributor.authorBarreiro de Acosta, Manuel-
dc.contributor.authorGETECCU Spanish Group-
dc.date.accessioned2023-01-13T18:29:27Z-
dc.date.available2023-01-13T18:29:27Z-
dc.date.issued2022-12-01-
dc.identifier.issn1578-9519-
dc.identifier.urihttp://hdl.handle.net/2445/192183-
dc.description.abstractPatients with inflammatory bowel disease (IBD) may require different immunosuppressive treatments throughout their illness. It is essential to assess the immunization status of patients at diagnosis or, if this is not possible, at least before the beginning of immunosuppressive therapy and, subsequently, administering the appropriate vaccines. Therefore, the aim of this work is to establish clear and concise recommendations on vaccination in patients with IBD in the different settings of our clinical practice including vaccination in children, during pregnancy, breastfeeding or on trips. This consensus document emphasises the differences between inactivated and attenuated vaccines and the different degrees of immunosuppression and correlates them with the administration of both mandatory and optional vaccines recommended to our patients with IBD. Finally, as a summary, 17 recommendations are established based on the available scientific evidence and expert opinion. A multidisciplinary team with extensive experience in IBD and vaccination, made up of specialists in gastroenterology, paediatrics, nursing and pharmacy, has participated in the preparation of these recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis.-
dc.format.extent14 p.-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherElsevier BV-
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1016/j.gastrohep.2022.03.012-
dc.relation.ispartofGastroenterología y Hepatología, 2022, vol. 45, num. 10, p. 805-818-
dc.relation.urihttps://doi.org/10.1016/j.gastrohep.2022.03.012-
dc.rightscc by-nc-nd (c) Ferreiro Iglesias, Rocío et al., 2022-
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/es/*
dc.sourceArticles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))-
dc.subject.classificationMalaltia de Crohn-
dc.subject.classificationColitis ulcerosa-
dc.subject.classificationVacunació-
dc.subject.classificationCribratge-
dc.subject.otherCrohn's disease-
dc.subject.otherUlcerative colitis-
dc.subject.otherVaccination-
dc.subject.otherMedical screening-
dc.titleRecomendaciones del Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa sobre la importancia, el cribado y la vacunación en pacientes con enfermedad inflamatoria intestinal-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/publishedVersion-
dc.date.updated2023-01-12T11:32:54Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
dc.identifier.pmid35577225-
Appears in Collections:Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)
Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Files in This Item:
File Description SizeFormat 
1-s2.0-S0210570522001406-main.pdf511.66 kBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons